acrylates. This fact has also been highlighted in the recent
review by Glorius et al.5f and others.5aÀe
structural domains having different biological functions.12b
The hybrid approach is a promising direction for medicinal
drugs that can effectively target multifactorial diseases.
Herein, we report a Rh(III)-catalyzed highly regioselective
dehydrogenative cross coupling of a large variety of
chromone derivatives with a broad range of olefins.
Recently Hong et al. developed a direct cross-coupling
between chromones and electron-deficient olefins at the
most electron-rich C3 position of chromone using Pd(OAc)2
as catalyst,7 and Jeganmohan et al. showed that the C5
position of chromone can be alkenylated using a chelation-
assisted ruthenium-catalyzed transformation (Figure 1).8
However, these two methodologies also suffer from limita-
tions in terms of the scope of olefins that can be efficiently
used.
In the wake of these reports and their associated limita-
tions and as part of our studies on the direct functionaliza-
tion of unactivated CÀH bonds,9 we planned to establish a
relatively general methodology for the direct regioselective
functionalization of chromone derivatives at the C5 posi-
tion with a variety of olefins using the keto group of
chromone as directing group.
Moreover, regioselective introduction of chemically ver-
satile alkene moieties to chromone, having multiple reac-
tive sites, is of immense importance as chromones are
present in many biologically active scaffolds.10 We also
thought that the coupling of chromones, if possible, with
quinone derivatives11 which themself are present in many
bioactive scaffolds could provide ready access to a new
class of so-called “hybrid molecules”.12 Hybrid molecules
can be defined as chemical entities with two or more
Figure 1. Dehydrogenative cross-coupling with chromones.
We started our optimization using the simple natural
products chromone13 (1a) and 1,4-naphthoquinone14 (2a)
for Rh(III)-catalyzed CDC. Our initial attempt based on
reported conditions6i,s using stoichiometric amounts of
anhydrous copper acetate as oxidant, 2 mol % of bis-
(pentamethylcyclopentadienylrhodium dichloride) and
8 mol % of AgSbF6 as an additive in tert-amyl alcohol at
100°C led toselective formation of thedesired product(3a)
with an impressive 70% yield (Table 1, entry 1). It is
remarkable; there are six CÀH bonds (two CÀH bonds in
chromone and four in 1,4-naphthoquinone) that can be
activated by transition metal and lead to different regioiso-
meric and dimerized products. Nevertheless, selective for-
mation of only one product was observed. Further screening
of various solvents resulted in the improved isolated yield
of 3a (77%) in 1,4-dioxane (Table 1, entries 1À6). Applica-
tionof copper(II) triflateasoxidant was notabletoprovide
the desired product in detectable amount (Table 1, entry 8).
Among other oxidants tested, Ag2O provided the best
yield with 73% in 17 h (Table 1, entry 10). Unfortunately,
the attempt to use air as an oxidant in the presence of
substoichiometric amounts of anhydrous copper acetate
was not successful (Table 1, entry 7). In further control
experiments, it was revealed that in the absence of Rh(III)
catalyst or additive (AgSbF6) the reaction did not provide
the desired product 3a (Table 1, entries 13 and 14). In
further optimization, it was found that the decrease of the
amount of copperacetate to1.2 equiv or 2ato1.5 equivstill
provided the desired product in comparable isolated yield
(77À79%) after 22 h (Table 1, entry 15 and 16) at 120 °C.
However, a decrease of both substances to 1.2 and 1.5 equiv
led to decreased yields of product (68%) (Table 1, entry 17).
It is important to note that the use of [RuCl2(p-cymene)]2 as
(6) For Rh-catalyzed important recent progress in oxidative cou-
€
pling, see: (a) Schroder, N.; Wincel-Delord, J.; Glorius, F. J. Am. Chem.
Soc. 2012, 134, 8298. (b) Huestis, M. P.; Chan, L.; Stuart, D. R.; Fagnou,
K. Angew.Chem., Int. Ed. 2011, 50, 1338. (c) Rakshit, S.; Grohmann, C.;
Besset, T.; Glorius, F. J. Am. Chem. Soc. 2011, 133, 2350. (d) Stuart,
D. R.; Alsabeh, P.; Kuhn, M.; Fagnou, K. J. Am. Chem. Soc. 2010, 132,
18326. (e) Rakshit, S.; Patureau, F. W.; Glorius, F. J. Am. Chem. Soc.
2010, 132, 9585. (f) Morimoto, K.; Hirano, K.; Satoh, T.; Miura, M.
Org. Lett. 2010, 12, 2068. (g) Wang, F.; Song, G.; Li, X. Org. Lett. 2010,
12, 5430. (h) Patureau, F. W.; Glorius, F. J. Am. Chem. Soc. 2010, 132,
9982. (i) Patureau, F. W.; Besset, T.; Glorius, F. Angew. Chem., Int. Ed.
2011, 50, 1064. (j) Xu, X.; Liu, Y.; Park, C.-M. Angew. Chem., Int. Ed.
2012, 51, 9372. (k) Wang, C.; Chen, H.; Wang, Z.; Chen, J.; Huang, Y.
Angew. Chem., Int. Ed. 2012, 51, 7242. (l) Muralirajan, K.; Parthasar-
athy, K.; Cheng, C.-H. Angew. Chem., Int. Ed. 2011, 50, 4169. (m) Wang,
H.; Glorius, F. Angew. Chem., Int. Ed. 2012, 51, 7318. (n) Li, B.-J.;
Wang, H.-Y.; Zhu, Q.-L.; Shi, Z.-J. Angew. Chem., Int. Ed. 2012, 51,
€
3948. (o) Shi, Z.; Schroder, N.; Glorius, F. Angew. Chem., Int. Ed. 2012,
51, 8092. (p) Zheng, L.; Wang, J. Chem.;Eur. J. 2012, 18, 9699. (q)
Patureau, F. W.; Besset, T.; Kuhl, N.; Glorius, F. J. Am. Chem. Soc.
2011, 133, 2154. (r) Song, G.; Chen, D.; Pan, C.-L.; Crabtree, R. H.; Li,
X. J. Org. Chem. 2010, 75, 7487. (s) Stuart, D. R.; Bertrand-Laperle, M.;
Burgess, K. M. N.; Fagnou, K. J. Am. Chem. Soc. 2008, 130, 16474.
(7) For Pd-catalyzed oxidative cross-coupling between the C-3 posi-
tion of chromone with quinone and the electron-deficient double bond,
see: (a) Moon, Y.; Hong, S. Chem. Commun. 2012, 48, 7191. (b) Kim, D.;
Hong, S. Org. Lett. 2011, 13, 4466.
(8) For Ru-catalyzed oxidative cross-coupling between the C-5 posi-
tion of chromone and acrylate, see: Padala, K.; Jeganmohan, M. Org.
Lett. 2011, 13, 6144.
(9) For the results of our group, see: (a) Samanta, R.; Antonchick,
A. P. Angew. Chem., Int. Ed. 2011, 50, 5217.
(10) For the biological activities of chromone, see: Sharma, S. K.;
Kumar, S.; Chand, K.; Kathuria, A.; Gupta, A.; Jain, R. Curr. Med.
Chem. 2011, 18, 3825.
(11) For the biological activities of 1,4 naphthoquinone, see: Babula,
P.; Adam, V.; Havel, L.; Kizek, R. Ceska Slov. Farm 2007, 56, 114.
(12) For the concept of hybrid molecules, see: (a) Tietze, L. F.; Bell,
H. P.; Chandrasekhar, S. Angew. Chem., Int. Ed. 2003, 42, 3996. (b)
Meunier, B. Acc. Chem. Res. 2008, 41, 69. (c) Decker, M. Curr. Med.
Chem. 2011, 18, 1464. (d) Krettli, A. U.; Adebayo, J. O.; Krettli, L. G.
Curr. Drug Targets 2009, 10, 261. (e) Mehta, G.; Singh, V. Chem. Soc.
Rev. 2002, 31, 324.
(13) Silici, S.; Kutluca, S. J. Ethanopharmacol. 2005, 99, 69.
(14) Binder, R. G.; Benson, M. E.; Flath, R. A. Phytochemistry 1989,
28, 2799.
B
Org. Lett., Vol. XX, No. XX, XXXX